1. Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men.
   Kaydos-Daniels SC, Miller WC, Hoffman I, Banda T, Dzinyemba W, Martinson F, Cohem MS, Hobbs MM
   Journal of  Clinical Microbiology 2003; 41:318-323.

summary               expert review

2. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. 
   Gaydos CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero DV, Schachter J.
   Journal of  Clinical Microbiology 2003; 41:304-309.

summary               

3. Determination of immunoglobulin A against Gardnerella vaginalis hemolysin, sialidase, and prolidase activities in vaginal fluid: implications for adverse pregnancy outcomes.
   Cauci S, Thorsen P, Schendel DE, Bremmelgaard A, Quadrifoglio F, Guaschino S
   Journal of  Clinical Microbiology 2003;41:435-438

summary               expert review

4. Detection of Mycoplasma genitalium by PCR amplification of the 16S rRNA gene.
   Jensen JS, Borre MB, Dohn B.
   J Clin Microbiol. 2003;41:261-266.

summary               expert review 

5. Evaluation of an enzyme immunoassay technique for detection of antibodies against Treponema pallidum.
   Castro R, Prieto ES, Santo I, Azevedo J, Exposto FdaL.
   J Clin Microbiol. 2003;41:250-253.

summary               expert review

6. Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae.
   Palmer HM, Mallison H, Wood RL, Herring AJ.
   J Clin Microbiol. 2003;41:835-837.

summary               expert review

7. Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors.
   Chong S, Jang D, Song X, Mahony J, Petrich A, Barriga P, Chernesky M.
   J Clin Microbiol. 2003;41:778-782.

summary               expert review

8. Diagnosing herpesvirus infections by real-time amplification and rapid culture.
   van Doornum GJJ, Guldemeester J, Osterhaus ADME, Niesters HGM
   J Clin Microbiol. 2003;41:576-580.

summary               expert review 

9. Longitudinal reliability of Focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.
   Cherpes TL, Ashley RL, Meyn LA, Hillier SL
   J Clin Microbiol. 2003;41:671-674

summary               expert review

10. Relation between Gram-stain and clinical criteria for diagnosing bacterial vaginosis with special reference to Gram grade II evaluation.
    Taylor-Robinson D, Morgan DJ, Sheehan M, Rosenstein IJ, Lamont RF. 
    Int J STD AIDS 2003;14:6-10.

summary               expert review

11. Construction and evaluation of internal control DNA for PCR amplification of Chlamydia trachomatis DNA from urine samples.
    Betsou F, Beaumont K, Sueur JM, Orfila J.
    J Clin Microbiol. 2003;41:1274-1276.

summary               expert review  

12. Improved sensitivity of the Chlamydia trachomatis Cobas Amplicor using an optimized procedured for preparation of specimens.
    Niederhauser C, Kaempf L.
    Eur J Clin Microbiol. 2003;22:118-121.

summary               expert review

13. Evaluation of a novel diagnostic test for bacterial vaginosis: 'the electronic nose'.
    Hay P, Tummon A, Ogunfile M, Adebiyi A, Adefowora A.
    Int J STD AIDS 2003;14:114-118.

summary               expert review

14. Bacterial vaginosis is a strong predictor of v and Chlamydia trachomatis infection.
    Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL.
    Clin Infect Dis. 2003;36:663-668.

summary               expert review

15. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolaou smear.
    Lara-Torre E, Pinkerton JS.
    Am J Obstet Gynecol. 2003;188:354-356.

summary               expert review

16. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease.
    Yudin MH, Hillier SL, Wiesenfeld HC, Krohn MA, Amortegui AA, Sweet RL.
    Am J Obstet Gynecol. 2003;188:318-323.

summary               expert review

17. "Shelf life" of Trichomonas vaginalis.
    Kingston MA, Bansal D, Carlin EM.
    Int J STD AIDS. 2003;14:28-29.

 summary               expert review

18. Performance characteristics of a glycoprotein G based oligopeptide (peptide 55) and two different methods using the complete glycoprotein as assays for detection of anti-HSV-2 antibodies in human sera.
    Nilsen A, Ulvestad E, Marsden H, Langeland N, Myrmel H, Matre R, Haarr L
    J Virol Meth. 2003;107:21-27

 summary               expert review

19. Phenotypic and genotypic methods for the detection of herpes simplex virus serotypes.
    Madhavan HN, Priya K, Bagyalakshmi R
    J Virol Meth. 2003;108:97-102

 summary               expert review

20. A novel polymerase chain reaction assay to detect Mycoplasma genitalium.
    Eastick K, Leeming JP, Caul EO, Horner PJ, Millar MR.
    J Clin Pathol: Mol Pathol. 2003;56:25-28

 summary               expert review 1      expert review 2

21. Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescense in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infection.
    Jones CS, Maple PAC, Andrews NJ, Paul ID, Caul EO.
    J Clin Pathol. 2003;56:225-230

 summary               expert review

22. Chancroid: clinical manifestations, diagnosis, and management.
    Lewis DA.
    Sex Transm Inf. 2003;79:68-71

  review